XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.22.4

Derivative Instruments | 12 Months Ended
--- | ---
Dec. 31, 2022
Text Block [Abstract] |
Derivative Instruments | Note 9: Derivative Instruments The Company has primarily entered into derivative instruments consisting of interest rate swaps to manage the risks associated with fluctuations in interest rates affecting the value of certain assets in the corporate segment. Additionally, the Company has insured interest rate swaps and inflation-linked swaps related to its insured debt issuances in the U.S. public finance insurance and the international and structured finance insurance segments. These derivatives do not qualify for the financial guarantee scope exception and are accounted for as derivative instruments. The Company’s international and structured finance insurance segment consolidated a VIE which is party to a cross currency swap, entered into to manage the variability in cash flows resulting from fluctuations in foreign currency rates. Credit Derivatives Sold The following tables present information about credit derivatives sold by the Company’s insurance operations that were outstanding as of December 31, 2022 and 2021. Credit ratings represent the lower of underlying ratings assigned to the collateral by Moody’s Investor Services (“Moody’s”), Standard & Poor’s Financial Services, LLC (“S&P”) or MBIA.
$ in millions |  | As of December 31, 2022 |
Credit Derivatives Sold |  | Weighted Average Remaining Expected Maturity |  |  | AAA |  |  | AA |  |  | A |  |  | BBB |  |  | Below Investment Grade |  |  | Total Notional |  |  | Fair Value Asset (Liability) |
Insured swaps |  |  | 13.7 Years |  |  | $ | — |  |  | $ | 50 |  |  | $ | 1,013 |  |  | $ | 227 |  |  | $ | 60 |  |  | $ | 1,350 |  |  | $ | — |
Total fair value |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  |  |  | $ | — |
$ in millions |  | As of December 31, 2021 |
Credit Derivatives Sold |  | Weighted Average Remaining Expected Maturity |  |  | AAA |  |  | AA |  |  | A |  |  | BBB |  |  | Below Investment Grade |  |  | Total Notional |  |  | Fair Value Asset (Liability) |
Insured swaps |  |  | 14.1 Years |  |  | $ | — |  |  | $ | 61 |  |  | $ | 1,136 |  |  | $ | 292 |  |  | $ | — |  |  | $ | 1,489 |  |  | $ | (1) |
Total fair value |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | (1) |  |  | $ | — |  |  | $ | — |  |  |  |  |  |  | $ | (1) |
Internal credit ratings assigned by MBIA on the underlying credit exposures are assigned by the Company’s surveillance group. In assigning an internal rating, current status reports from issuers and trustees, as well as publicly available transaction-specific information, are reviewed. The maximum potential amount of future payments (undiscounted) on insured swaps that are primarily insured interest rate swaps is estimated as the net interest settlements plus principal payments where applicable, on amortizing swaps. MBIA may hold recourse provisions through subrogation rights of the swap counterparty, whereby if MBIA makes a claim payment, it may be entitled to receive net swap settlements from the issuer under the swap agreement. Counterparty Credit Risk The Company manages counterparty credit risk on an individual counterparty basis through master netting agreements covering derivative instruments in the corporate segment. These agreements allow the Company to contractually net amounts due from a counterparty with those amounts due to such counterparty when certain triggering events occur. The Company only executes swaps under master netting agreements, which typically contain mutual credit downgrade provisions that generally provide the ability to require assignment or termination in the event either MBIA or the counterparty is downgraded below a specified credit rating. Under these agreements, the Company may receive or provide cash, U.S. Treasury or other highly rated securities to secure counterparties’ exposure to the Company or its exposure to counterparties, respectively. Such collateral is available to the holder to pay for replacing the counterparty in the event that the counterparty defaults. As of December 31, 2022 and 2021, the Company did not hold or post cash collateral to derivative counterparties. As of December 31, 2022 and 2021, the Company had securities with a fair value of $73 million and $159 million, respectively, posted to derivative counterparties and these amounts are included within “Fixed-maturity securities held as available-for-sale, at fair value” on the Company’s consolidated balance sheets. As of December 31, 2022 and 2021, the fair value on one Credit Support Annex (“CSA”) was a liability of $ 1 million and an asset of $1 million, respectively. This CSA governs collateral posting requirements between MBIA and its derivative counterparties. The Company did not receive collateral due to the Company’s credit rating, which was below the CSA minimum credit ratings level for holding counterparty collateral. As of December 31, 2022 and 2021, the counterparty was rated Aa3 by Moody’s and A+ by S&P. Financial Statement Presentation The fair value of amounts recognized for eligible derivative contracts executed with the same counterparty under a master netting agreement, including any cash collateral that may have been received or posted by the Company, is presented on a net basis in accordance with accounting guidance for the offsetting of fair value amounts related to derivative instruments. Insured swaps are not subject to master netting agreements. VIE derivative assets and liabilities are not presented net of any master netting agreements. Counterparty netting of derivative assets and liabilities offsets balances in “Interest rate swaps”, when applicable. The following tables present the total fair value of the Company’s derivative assets and liabilities by instrument and balance sheet location, before counterparty netting, as of December 31, 2022 and 2021:
|  | December 31, 2022 |
In millions |  |  |  |  | Derivative Assets (1) |  |  | Derivative Liabilities (1) |
Derivative Instruments |  | Notional Amount Outstanding |  |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  |  | Fair Value |
Not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Insured swaps |  | $ | 1,350 |  |  |  | Other assets |  |  | $ | — |  |  |  | Derivative liabilities |  |  | $ | — |
Interest rate swaps |  |  | 380 |  |  |  | Other assets |  |  |  | — |  |  |  | Derivative liabilities |  |  |  | (49) |
Interest rate swaps-embedded |  |  | 194 |  |  |  | Medium-term notes |  |  |  | 1 |  |  |  | Medium-term notes |  |  |  | (2) |
Currency swaps-VIE |  |  | 36 |  |  |  | Other assets-VIE |  |  |  | — |  |  |  | Derivative liabilities-VIE |  |  |  | (6) |
Total non-designated derivatives |  | $ | 1,960 |  |  |  |  |  |  | $ | 1 |  |  |  |  |  |  | $ | (57) |
(1)—In accordance with the accounting guidance for derivative instruments and hedging activities, the balance sheet location of the Company’s embedded derivative instruments is determined by the location of the related host contract.
|  | December 31, 2021 |
In millions |  |  |  |  | Derivative Assets (1) |  |  | Derivative Liabilities (1) |
Derivative Instruments |  | Notional Amount Outstanding |  |  | Balance Sheet Location |  |  | Fair Value |  |  | Balance Sheet Location |  |  | Fair Value |
Not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Insured swaps |  | $ | 1,489 |  |  |  | Other assets |  |  | $ | — |  |  |  | Derivative liabilities |  |  | $ | (1) |
Interest rate swaps |  |  | 399 |  |  |  | Other assets |  |  |  | 1 |  |  |  | Derivative liabilities |  |  |  | (130) |
Interest rate swaps-embedded |  |  | 206 |  |  |  | Medium-term notes |  |  |  | — |  |  |  | Medium-term notes |  |  |  | (9) |
Currency swaps-VIE |  |  | 50 |  |  |  | Other assets-VIE |  |  |  | 9 |  |  |  | Derivative liabilities-VIE |  |  |  | — |
Total non-designated derivatives |  | $ | 2,144 |  |  |  |  |  |  | $ | 10 |  |  |  |  |  |  | $ | (140) |
(1)—In accordance with the accounting guidance for derivative instruments and hedging activities, the balance sheet location of the Company’s embedded derivative instruments is determined by the location of the related host contract. The following table presents the effect of derivative instruments on the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020:
In millions |  |  |  | Years Ended December 31, |
Derivatives Not Designated as Hedging Instruments |  | Location of Gain (Loss) Recognized in Income on Derivative
| 2022 |  |  | 2021 |  |  | 2020 |
Insured credit default swaps |  | Net gains (losses) on financial instruments at fair value and foreign exchange |  | $ | — |  |  | $ | — |  |  | $ | 6 |
Insured swaps |  | Net gains (losses) on financial instruments at fair value and foreign exchange |  |  | 1 |  |  |  | — |  |  |  | — |
Interest rate swaps |  | Net gains (losses) on financial instruments at fair value and foreign exchange |  |  | 79 |  |  |  | 18 |  |  |  | (42) |
Currency swaps-VIE |  | Net gains (losses) on financial instruments at fair value and foreign exchange-VIE |  |  | (15) |  |  |  | 3 |  |  |  | (2) |
All other |  | Net gains (losses) on financial instruments at fair value and foreign exchange |  |  | — |  |  |  | — |  |  |  | (15) |
Total |  |  |  | $ | 65 |  |  | $ | 21 |  |  | $ | (53) |

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI https://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration